The Sputnik V vaccine is more effective against the Delta strain of the coronavirus than any other vaccine that published results on that strain, the Russian Direct Investment Fund said on the vaccine’s Twitter account.
According to the statement, “Sputnik V is more efficient against the Delta variant of coronavirus, first detected in India, than any other vaccine that published results on this strain so far – the Gamaleya Center study submitted for publication in an international peer-reviewed journal.”
In late April, the head of the Gamaleya National Research Center for Epidemiology and Microbiology, which developed the vaccine, said Sputnik V produces enough antibodies to battle the Delta strain.
Russia was the world’s first to register a coronavirus vaccine on August 11, 2020. It also applied for registration of this drug in the EU, as well as with the World Health Organization.
Over 30 countries have begun mass vaccination with Sputnik V.